These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19363377)

  • 41. Patterns of methamphetamine use and symptoms of depression among young adults in northern Thailand.
    Sutcliffe CG; German D; Sirirojn B; Latkin C; Aramrattana A; Sherman SG; Celentano DD
    Drug Alcohol Depend; 2009 May; 101(3):146-51. PubMed ID: 19153017
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary and substance-induced psychotic disorders in methamphetamine users.
    Hides L; Dawe S; McKetin R; Kavanagh DJ; Young RM; Teesson M; Saunders JB
    Psychiatry Res; 2015 Mar; 226(1):91-6. PubMed ID: 25677394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences between methamphetamine users and cocaine users in treatment.
    Copeland AL; Sorensen JL
    Drug Alcohol Depend; 2001 Mar; 62(1):91-5. PubMed ID: 11173172
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users.
    Lapworth K; Dawe S; Davis P; Kavanagh D; Young R; Saunders J
    Addict Behav; 2009 Apr; 34(4):380-5. PubMed ID: 19097704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.
    Anderson AL; Li SH; Markova D; Holmes TH; Chiang N; Kahn R; Campbell J; Dickerson DL; Galloway GP; Haning W; Roache JD; Stock C; Elkashef AM
    Drug Alcohol Depend; 2015 May; 150():170-4. PubMed ID: 25818061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Depressive symptoms among amphetamine and cocaine users before and after substance abuse treatment.
    Riehman KS; Iguchi MY; Anglin MD
    Psychol Addict Behav; 2002 Dec; 16(4):333-7. PubMed ID: 12503906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methamphetamine dependence: a closer look at treatment response and clinical characteristics associated with route of administration in outpatient treatment.
    Rawson RA; Gonzales R; Marinelli-Casey P; Ang A
    Am J Addict; 2007; 16(4):291-9. PubMed ID: 17661197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Review of Methamphetamine Dependence and Withdrawal Treatment: A Focus on Anxiety Outcomes.
    Hellem TL
    J Subst Abuse Treat; 2016 Dec; 71():16-22. PubMed ID: 27776672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Health outcomes associated with methamphetamine use among young people: a systematic review.
    Marshall BD; Werb D
    Addiction; 2010 Jun; 105(6):991-1002. PubMed ID: 20659059
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methamphetamine and paranoia: the methamphetamine experience questionnaire.
    Leamon MH; Flower K; Salo RE; Nordahl TE; Kranzler HR; Galloway GP
    Am J Addict; 2010; 19(2):155-68. PubMed ID: 20163388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Persistent Microstructural Deficits of Internal Capsule in One-Year Abstinent Male Methamphetamine Users: a Longitudinal Diffusion Tensor Imaging Study.
    Zhuang W; Tang Y; Zhong N; Jiang H; Du J; Wang J; Zhao M
    J Neuroimmune Pharmacol; 2016 Sep; 11(3):523-30. PubMed ID: 27115910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers.
    Camacho A; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):217-30. PubMed ID: 15780692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Depression mediates and moderates effects of methamphetamine use on sexual risk taking among treatment-seeking gay and bisexual men.
    Fletcher JB; Reback CJ
    Health Psychol; 2015 Aug; 34(8):865-9. PubMed ID: 25581704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hostility among methamphetamine users experiencing psychotic symptoms.
    McKetin R; McLaren J; Lubman DI; Hides L
    Am J Addict; 2008; 17(3):235-40. PubMed ID: 18464001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings.
    Panenka WJ; Procyshyn RM; Lecomte T; MacEwan GW; Flynn SW; Honer WG; Barr AM
    Drug Alcohol Depend; 2013 May; 129(3):167-79. PubMed ID: 23273775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methamphetamine use in an early psychosis service: a cross-sectional retrospective cohort study.
    McInnis P; Lee A
    Australas Psychiatry; 2019 Aug; 27(4):383-387. PubMed ID: 31264898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differences in clinical features and gut microbiota between individuals with methamphetamine casual use and methamphetamine use disorder.
    He L; Yang BZ; Ma YJ; Wen L; Liu F; Zhang XJ; Liu TQ
    Front Cell Infect Microbiol; 2023; 13():1103919. PubMed ID: 36909722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gender differences in methamphetamine use and responses: a review.
    Dluzen DE; Liu B
    Gend Med; 2008 Mar; 5(1):24-35. PubMed ID: 18420163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methamphetamine use is associated with high levels of depressive symptoms in adolescents and young adults in Rural Chiang Mai Province, Thailand.
    DiMiceli LE; Sherman SG; Aramrattana A; Sirirojn B; Celentano DD
    BMC Public Health; 2016 Feb; 16():168. PubMed ID: 26893284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methamphetamine dependence and human immunodeficiency virus risk behavior.
    Rawson RA; Gonzales R; Pearce V; Ang A; Marinelli-Casey P; Brummer J;
    J Subst Abuse Treat; 2008 Oct; 35(3):279-84. PubMed ID: 18329225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.